BioSpace News Archive

Mind health concept. Human face side view silhouette and alter ego

Schizophrenia

5 Schizophrenia Candidates Chasing BMS’ KarXT

As the FDA prepares to render a verdict on BMS’ closely watched schizophrenia drug, BioSpace takes a closer look at the late-stage pipeline for this neuropsychiatric disorder.

September 23, 2024

·

6 min read

·

Heather McKenzie

3D illustration of an antibody-drug conjugate

Antibody-drug conjugate (ADC)

AstraZeneca, Daiichi Sankyo’s ADC Flops in Phase III Breast Cancer on Heels of Lung Cancer Stumble

Monday’s failure to improve overall survival in breast cancer “further dents belief” in the companies’ Dato-DXd and “likely complicates regulatory discussions for approval of this indication,” Jefferies analyst Peter Welford wrote in a note to investors.

September 23, 2024

·

3 min read

·

Tristan Manalac

Pictured: A Bristol Myers Squibb among some bushes

Layoffs

BMS Will Lay Off 79 in Lawrenceville, NJ, Bringing City’s Employee Cuts to 1,134

Bristol Myers Squibb is continuing its cost-savings measures with layoffs in Lawrenceville, New Jersey. The company announced earlier this year that it will eliminate 2,200 jobs by the end of 2024 in a bid to save $1.5 billion through 2025.

September 23, 2024

·

2 min read

·

Angela Gabriel

Pictured: Blue Sanofi sign on building in Germany at night

Approvals

Sanofi Secures First-Line Nod for Sarclisa in Multiple Myeloma, Tees Up Competition With J&J

With Friday’s approval, Sanofi’s anti-CD38 antibody Sarclisa will go head-to-head with the first such therapy for multiple myeloma, Johnson & Johnson’s Darzalex, which raked in nearly $10 billion last year.

September 23, 2024

·

2 min read

·

Tristan Manalac

Group of employees being laid off by their company

Layoffs

Athira Pharma to Lay Off 70% of Workforce

Athira Pharma will cut about 49 positions, including two people in the C-suite. The announcement follows the company’s disappointing results for its investigational Alzheimer’s therapy.

September 23, 2024

·

1 min read

·

Angela Gabriel

From Left to right: Lori Ellis, Sherrine Eid, Colin Zick, Nagisa Sakurai, Mike Walker, Sarah Glaven

Business

The White House, Microsoft, SaS, Foley Hoag & Astellas Offer AI Guidance to Investors. Part One: The Present

Before companies and investors look towards the future, they must first understand the opportunities and challenges AI presents to them. From the benefits included in advancing processes to cybersecurity hazards, AI innovation is a balanced scale of oppportunities and risks.

September 23, 2024

·

10 min read

·

Lori Ellis

Photo of a judge's gavel, a balance and a stack of papers

Legal

Appeals Court Breathes New Life Into PhRMA’s Legal Challenge to IRA

A lawsuit filed by the Pharmaceutical Research and Manufacturers of America, which claims the Inflation Reduction Act’s Medicare Drug Price Negotiation Program is unconstitutional, now goes back to a lower Texas court.

September 23, 2024

·

2 min read

·

Tristan Manalac

Press Releases

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union

September 23, 2024

·

26 min read

Press Releases

Kangpu Completed Bridging Clinical Study of KPG-818 in China